NCT05233852 (OVERGEND) is a clinical trial of "Do not do" recommendation in Severe Adverse Event, sponsored by Universidad Miguel Hernandez de Elche.

Who is sponsoring NCT05233852?

NCT05233852 is sponsored by Universidad Miguel Hernandez de Elche.

What drugs are being tested in NCT05233852?

Interventions in NCT05233852: "Do not do" recommendation.

What condition does NCT05233852 study?

NCT05233852 studies Severe Adverse Event.

Is NCT05233852 still recruiting?

NCT05233852 is currently active, enrolled. Last updated 13 May 2024.

Last reviewed 2024-05-13 · How we verify

NCT05233852: OVERGEND

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Gender Bias in the Overuse Studies Conducting in Primary Care

Active, enrolled Last updated 13 May 2024

What this trial tests

trial testing "Do not do" recommendation in Severe Adverse Event in 1,538 participants. Participants enrolled and being followed up; not accepting new ones.

Timeline

1 May 2022

Primary endpoint
31 May 2023

31 December 2024

Quick facts

Lead sponsor	Universidad Miguel Hernandez de Elche
Status	Active, enrolled
Study type	OBSERVATIONAL
Enrollment	1,538
Start date	1 May 2022
Primary completion	31 May 2023
Estimated completion	31 December 2024
Sites	1 location across Spain

Drugs / interventions tested

"Do not do" recommendation

Conditions studied

Severe Adverse Event — all drugs for Severe Adverse Event →

Sponsor

Universidad Miguel Hernandez de Elche — full company profile →

Who can join

18 and older, any sex, with Severe Adverse Event. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The purpose of this study is to analyze whether the differences between men and women in the frequency of adverse events due to ignoring "Do not do" recommendations in primary care setting are due to biological causes or gender bias.

Publications & conference data

4 peer-reviewed publications reference this trial (live from Europe PMC):

Identification of low-value practices susceptible to gender bias in primary care setting.
Pérez-Jover V, Sánchez-García A, Lopez-Pineda A, Carrillo I, et al · · 2024 · cited 3× · PMID 38851666 · DOI 10.1186/s12875-024-02456-8
Epidemiological study on gender bias and low-value practices in primary care: a study protocol.
Carrillo I, Lopez-Pineda A, Pérez-Jover V, Guilabert M, et al · · 2023 · cited 3× · PMID 37160394 · DOI 10.1136/bmjopen-2022-070311
Low-value practices in primary care: a cross-sectional study comparing data between males and females in Spain.
Mira JJ, Carratalá-Munuera C, García-Torres D, Soriano C, et al · · 2024 · cited 1× · PMID 39581714 · DOI 10.1136/bmjopen-2024-089006
Gender Disparities in Adverse Events Resulting From Low-Value Practices in Family Practice in Spain: A Retrospective Cohort Study.
Mira JJ, Carratala-Munuera C, Vicente MA, Astier-Peña MP, et al · · 2024 · cited 1× · PMID 39081783 · DOI 10.3389/ijph.2024.1607030

Verify or expand the search:

Other Universidad Miguel Hernandez de Elche trials

Trials by the same sponsor.

NCT07498569 — Effects of Percutaneous Electrical Stimulation in Patients With Chronic Supraspinatus Tendinopathy · NA · not yet recruiting
NCT07237971 — Cocreating Action to Improve Rationality in the Health System · NA · recruiting
NCT07146789 — Home-based Graded Repetitive Arm Supplementary Program for Quality of Life and Functional Upper Limb Recovery · NA · recruiting
NCT06889389 — Effects of Education and Exercise on Pain, Psychosocial Factors, and Upper Limb Function in Non-specific Neck Pain. · NA · recruiting
NCT07192835 — Effect of Fruit Elicitation With Melatonin on Human Health · NA · completed

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT05233852 (US National Library of Medicine, public domain)
Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Universidad Miguel Hernandez de Elche
Last refreshed: 13 May 2024

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05233852.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing